Real-time enrollment status for this metastatic castration-resistant prostate cancer clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 3:25 PM UTC
| NCT Number | NCT06842498 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Castration-Resistant Prostate Cancer |
| Phase | PHASE2 |
| Target Enrollment | 75 participants |
| Active Locations | 23 sites in the US |
| Sponsor | Kyntra Bio |
| Last Updated on CT.gov | August 17, 2026 (Aug 17, 2026) |
As of October 12, 2026: Clinical trial NCT06842498 is currently recruiting participants. This phase2 study for metastatic castration-resistant prostate cancer is actively seeking new participants at 23 locations across the United States. The study is sponsored by Kyntra Bio. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06842498 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 23 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06842498 was last updated Aug 17, 2026 (August 17, 2026). HelloStudys verifies this status automatically.